10x Genomics is trading 4.18% down at $77.33 as renewed inflation and interest-rate concerns weigh on U.S. equities.
- The Nasdaq Composite is down 1.05%, providing a stronger broad-market explanation than any new company-specific announcement.
- Brent crude rose approximately 1.3% to $100.55, while the 10-year Treasury yield reached 4.99%, pressuring growth-stock valuations.
- Recent optimism from earnings, Atera demand, and analyst target increases appears to be prior context, not today’s catalyst.